Bamco Inc. NY Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Bamco Inc. NY cut its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 53.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 138,220 shares of the real estate investment trust’s stock after selling 161,359 shares during the quarter. Bamco Inc. NY’s holdings in Healthpeak Properties were worth $2,802,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of DOC. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties during the fourth quarter valued at approximately $30,000. Covestor Ltd boosted its position in shares of Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 1,152 shares during the period. AdvisorNet Financial Inc increased its stake in shares of Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC bought a new stake in shares of Healthpeak Properties during the 4th quarter valued at $45,000. Institutional investors own 93.57% of the company’s stock.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of the business’s stock in a transaction dated Monday, April 28th. The shares were purchased at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now owns 201,863 shares in the company, valued at $3,568,937.84. This represents a 5.95 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the completion of the purchase, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. The trade was a 0.52 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.23% of the company’s stock.

Wall Street Analysts Forecast Growth

DOC has been the subject of a number of analyst reports. Wedbush cut their price target on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Thursday, May 1st. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Scotiabank cut their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Finally, Robert W. Baird lowered their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $23.42.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $17.57 on Tuesday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a twelve month low of $17.33 and a twelve month high of $23.26. The company’s 50-day moving average price is $19.32 and its 200-day moving average price is $20.37. The company has a market cap of $12.21 billion, a PE ratio of 50.20, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.45 earnings per share. On average, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a dividend, which was paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th were paid a dividend of $0.1017 per share. This represents a yield of 6.5%. The ex-dividend date of this dividend was Thursday, April 17th. Healthpeak Properties’s payout ratio is 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.